Start A Thread

Rate Intersect ENT

  • Culture

  • Compensation

  • Opportunity for advancement

  • Realistic plan attainment



In our drive to help people in the medical sales industry we are gathering salary data. This information will be collated, analyzed and number crunched. Medtechy’s overall goal is to help the medical sales industry make more informed decisions when changing jobs and also keep employers and recruiters honest

Take 30 seconds and let us know your current deal.*

About The Position


* We guarantee all data collected is completely anonymous and will only be used for the benefit of future visitors.


Hot Ticker Articles

According to a new survey, doctors find pharma sales calls redundant

4 Easy Steps To Reboot Your Sales Territory In The Second Half Of The Year

Can TransEnterix overtake Intuitive Surgical in the robotic surgery race?

MedReps 2017 Medical Sales Salary Report

Boost sales with a simple 7 step pre-call plan

What is medtechy and how can it benefit medical sales reps?

4 Tips for Managing a New Medical Sales Territory

Stryker still going after ex-rep, despite bankruptcy

Is sexual wellness startup, Nuelle, the new model for medical device investing?

Study: Inside the Relationships between Surgeons and Medical Device Representatives

Job Listings

Keep Stocking Those Shelves Intersect ENT

2 hours ago

Intersect paid him like 75 grand last year. Of course he does a lot of business with them.

I can't wait for SINUVA

4 days ago

Too bad you dorks have to wait until January 5th at a minimum.

Note to Management: Reasons Many Are Leaving

2 weeks ago

and why would they be? Sales grew 24% last quarter but sales expenses were considerably down. Reps aren't getting paid what they used to but sales continue to grow. When will you sheep wake up and realize Intersect is turning into a pharma company?

Intersect ENT Earnings $XENT

3 weeks ago

MENLO PARK, Calif.--(BUSINESS WIRE)-- Intersect ENT, Inc. (NASDAQ:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today reported financial results for the second quarter ended June 30, 2017.

Second Quarter Financial Highlights

  • Second quarter 2017 revenue was $24.0 million, a 24% increase over the second quarter 2016
  • Second quarter 2017 gross margin was 85% compared to 84% in the second quarter 2016

Second Quarter Business Highlights

  • The …

All is great

3 weeks ago

All the ENT companies are in disarray except Intersect. What's in the water over there?

Intersect ENT Insider Selling Part Deux

2 months ago

Face it, Lisa has more shares than she knows what to do with. Ask why they aren't a greater part of your compensation.They will laugh. You should then understand what the E team thinks of the reps. Replaceable.

Earnings Call

3 months ago

I heard the had to lock the sheep up at night in the town he lives in.


4 months ago

I am sure Binney.